WASHINGTON, Nov. 17 (TodayViralUSA) — The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a White House official confirmed on Tuesday, a day before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on whether to send her nomination to the full Senate.
Axios first reported the decision. Republicans held a one-vote majority on the committee, meaning a single GOP defection could have sunk the nomination if all Democrats were opposed, according to The Hill and CNBC.
Doubts from Republican senators
Overton, a preventive medicine physician and deputy director of the White House Domestic Policy Council, was nominated in August. She previously served as chief policy officer at the America First Policy Institute, a conservative think tank.
Committee Chairman Bill Cassidy, a Louisiana Republican and physician, had questioned whether she had enough managerial experience to run the agency and had voiced “strong concerns” about her role in the administration’s push to change childhood vaccine recommendations. In August, Overton appeared with President Donald Trump as he announced an executive order calling for fewer federally recommended childhood vaccinations and for splitting the measles, mumps and rubella shot into three separate injections, CNBC reported.
After the withdrawal, Cassidy wrote on X that the White House “abandoned a viable confirmation path for Dr. Overton,” saying his conversations with her convinced him “she would follow the science.” He said the final sticking point was that anti-abortion senators sought assurances from the administration on “life issues,” and that the administration withdrew Overton “rather than make such commitments.”
“Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats,” said Cassidy, who lost his reelection bid and leaves Congress in early January.
A new direction
“We need to go in a new direction at FDA, and everybody fully supports Secretary Kennedy’s vision to Make America Healthy Again,” a senior administration official told Axios. Two people familiar with the matter told Reuters the White House is weighing Sen. Roger Marshall of Kansas, a former obstetrician who also lost his reelection bid, as a replacement.
Overton had also faced criticism from Democrats over her views on the abortion pill mifepristone, from some Make America Healthy Again activists over her corporate ties, and from anti-vaping advocates over her defense of the FDA’s May authorization of fruit-flavored vapes.
Agency without a permanent leader
The FDA has been without a permanent commissioner since Dr. Marty Makary resigned in May, in part over the administration’s decision to authorize several fruit-flavored vaping products, NBC News reported. Kyle Diamantas, the deputy commissioner for food, is serving as acting commissioner.
The agency is due to complete a safety review of mifepristone by March 2027, one of the most consequential decisions it faces. Republicans are racing to confirm Trump’s remaining nominees before Democrats take control of the Senate in January, the Associated Press reported.
Sources & Credits
- Axios: Scoop: White House drops Heidi Overton’s FDA nomination
- NBC News: White House drops Dr. Heidi Overton’s FDA nomination as commissioner
- Reuters via CNBC: Trump withdraws Heidi Overton as nominee to lead FDA, sources say
- The Hill: White House pulls nomination of Heidi Overton to lead FDA
- Associated Press: White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
Image: Main entrance of FDA Building 1, Silver Spring, Maryland. Photo by the U.S. Food and Drug Administration, in the public domain, via Wikimedia Commons.




Join the conversation